• Bayzed Health posted profit of RMB 18.5 million, returning to profit from a loss a year earlier; EPS was RMB 0.01.
• Revenue rose 1.7% to RMB 584.5 million, supported by stable operations; gross profit increased 2.2% to RMB 108.6 million.
• Operating profit climbed to RMB 35.6 million, helped by higher other net income of RMB 6.7 million from interest on IPO proceeds.
• Outpatient and emergency visits increased 5.5% to 380,000; Grade III/IV surgeries rose 30.1% to 3,767 across self-owned hospitals.
• Full-cycle health management enrolled 1,298 users; incremental follow-up-related medical service revenue totaled RMB 16.6 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bayzed Health Group Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260828-12305097), on August 28, 2026, and is solely responsible for the information contained therein.